ArticleRetina (Philadelphia, Pa.)2019

THREE-YEAR OUTCOMES IN A RANDOMIZED SINGLE-BLIND CONTROLLED TRIAL OF INTRAVITREAL RANIBIZUMAB AND ORAL SUPPLEMENTATION WITH DOCOSAHEXAENOIC ACID AND ANTIOXIDANTS FOR DIABETIC MACULAR EDEMA.

María Lafuente et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.